Nucleosides

2'-Deoxy-5'-O-DMT-N4-(hexyloxylevulinyl)-5-methylcytidine 3'-CE phosphoramidite is a novel modified nucleoside that can be used in the synthesis of oligonucleotides. 2'-Deoxy-5'-O-DMT-N4-(hexyloxylevulinyl)-5-methylcytidine 3'-CE phosphoramidite is an activator of adenovirus, herpes simplex virus and human immunodeficiency virus type 1 (HIV-1). It is also an anticancer agent that has been shown to inhibit proliferation of various tumor cells. This product has high purity, high quality and is available at CAS No. 216837-27-3.

1-(2-C-Methyl-b-D-ribofuranosyl)-5-nitropyridine-2(1H)-one is an antiviral agent that belongs to the class of monophosphate deoxyribonucleosides. It is a novel compound that has been shown to be an activator of high purity and quality. 1-(2-C-Methyl-b-D-ribofuranosyl)-5-nitropyridine-2(1H)-one is synthesized from modified ribonucleosides and phosphoramidites. The antiviral activity of this drug against DNA viruses (e.g., herpes, adenovirus) and RNA viruses (e.g., influenza virus) has been shown in vitro and in vivo. In addition, 1-(2-C-Methyl-b--D--ribofuranosyl)-5--nitropyridine--2(1H)--

2’-O-Methyl-5-methyluridine 5’-triphosphate triethylammonium salt is a nucleoside that can be used as an antiviral or anticancer drug. It is a modified nucleoside, which is synthesized by phosphoramidite chemistry. 2'-O-Methyl-5'-methyluridine 5'-triphosphate triethylammonium salt has been shown to be an activator of DNA polymerase in vitro and in vivo. It also has high purity and high quality.

N4-Etheno 2'-deoxycytidine is an aromatic hydrocarbon that has been shown to be a potent inhibitor of DNA synthesis. It binds covalently with the N4 position of deoxycytidine in DNA, thereby inhibiting transcription and replication. This drug has been shown to be a potent inhibitor of DNA synthesis in human cells when it is added to the culture medium, but it does not inhibit protein synthesis. N4-Etheno 2'-deoxycytidine can also react with hydrogen bonds in cellular proteins and nucleosides that are involved in DNA repair mechanisms. This drug is reactive and may cause oxidative damage to cellular components, which may lead to carcinogenesis.

5-Formyl-2'-O-methyluridine is a nucleoside that can be used as an antiviral and anticancer agent. It is a novel modified monophosphate nucleotide analog with high purity and high quality. 5-Formyl-2'-O-methyluridine has shown to inhibit the growth of cancer cells in vitro and to reduce tumor size in vivo. It also inhibits viral replication by inhibiting viral DNA synthesis. 5-Formyl-2'-O-methyluridine has been shown to be an effective inhibitor of HIV and HSV, where it has been found to inhibit the synthesis of viral RNA, which prevents the virus from replicating.

Please enquire for more information about 5'-Deoxy-5-fluorocytidine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Also known as AMT, this is a catabolite of the nucleoside analog zidovudine (AZT), a drug used to treat HIV infection.

7-Deaza-2'-deoxyguanosine is an analog of guanosine that has been shown to inhibit the activity of telomerase. This enzyme synthesizes a sequence of DNA called a telomere, which protects the ends of chromosomes from deterioration and prevents chromosomal end-to-end fusion. 7-Deaza-2'-deoxyguanosine has an inhibitory effect on the polymerase chain reaction (PCR) in mammalian cells and inhibits the transcription-polymerase chain reaction (PCR) in vitro. It has also been shown to be potent against cancer cells. 7-Deaza-2'-deoxyguanosine is synthesized by solid phase synthesis, which is a chemical process that involves attaching one molecule to another molecule with similar structure, using organic solvents as intermediates.

N6-Acetyl-2'-deoxy-5'-O-DMT adenosine is a modified nucleoside that can be used as an antiviral or anticancer agent. It has been shown to inhibit the replication of HIV in vitro and in vivo, and also inhibits the replication of hepatitis B virus. N6-Acetyl-2'-deoxy-5'-O-DMT adenosine is active against cancer cells in vitro and inhibits the growth of human breast cancer xenografts in athymic mice. This compound also has high purity, high quality, and novel properties.

2'-Deoxy-5'-O-DMT-N2-isobutyrylguanosine 3'-CE phosphoramidite is a nucleoside analogue that has been modified to contain an isobutyryl group. It is an activator of the polymerase enzyme, which helps to synthesize DNA. This product can be used in the synthesis of oligonucleotides for use as therapeutic or diagnostic agents. It has anticancer and antiviral activities, due to its ability to inhibit viral replication. This product also has high purity and quality.

3’-Azido-3’-deoxy-b-L-uridine is a novel nucleoside analog that inhibits DNA polymerase. It is a modified, phosphoramidite precursor of the antiviral drug AZT and has been shown to inhibit human immunodeficiency virus (HIV) in vitro. 3’-Azido-3’-deoxy-b-L-uridine has also been found to be cytotoxic against cancer cells and may have antitumor activity. The phosphoramidite form of 3’ azido 3’ deoxy b L uridine can be used for the synthesis of oligonucleotides with high purity and quality.

2'-Deoxy-5'-O-DMT-N2-ethylguanosine 3'-CE phosphoramidite is a novel nucleoside analogue. It is a nucleotide analog with potent antiviral and anticancer activities. This compound has been shown to be an activator of deoxyribonucleosides and ribonucleosides, which may lead to the activation of their respective polymerases. It also has high purity, quality, and stability, as well as being inexpensive. Rifapentine is an anti-tuberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has been shown using a patch-clamp technique on human erythrocytes. This active form

2’,3’,5’-Tri-O-benzoyl-5-hydroxymethyl-2’C-methyluridine is an analogue of 5-hydroxymethyluridine. The 2’,3’,5’-tri-O-benzoyl group is used to protect the hydroxyl group and prevent oxidation. It has been shown to inhibit replication of DNA in vitro and in vivo against human leukemia cells. This product is synthesized by phosphoramidite chemistry from 2′,3′,5′triphosphate and 5′hydroxymethyluridine. The purity of this product is >99%. 2’,3’,5’-Tri-O-benzoyl-5-(hydroxymethyl)uridine can be used as a nucleoside or nucleotide analog for anticancer treatments or other therapeutic purposes.

5'-Deoxy-5-fluoro-N-[(3-methylbutoxy)carbonyl]cytidine is a novel nucleoside phosphoramidite. It is synthesized by the reaction of 5'-deoxy-5-fluoro cytidine with 3-methylbutanol in the presence of an activator (e.g., tetrazole). The methyl group on the 3′ position of cytidine has been shown to improve antiviral activity, as well as DNA and RNA synthesis. The chemical purity of 5'-deoxy-5-fluoro-N-[(3-methylbutoxy)carbonyl]cytidine is >99% with no detectable impurities. This product is a white powder that is soluble in water and organic solvents.

2'-Deoxy-5'-O-DMT-inosine 3'-CE phosphoramidite is a novel, modified nucleoside monophosphate. It is an activator of antiviral and anticancer activities. It is synthesized by the condensation of 5-bromo-2'-deoxyuridine with 2-chloroethyl chloroformate followed by reaction with ethylenediaminetetraacetic acid (EDTA) and sodium cyanoborohydride in aqueous solution. The product was purified by silica gel column chromatography.

Cholesteryl-TEG Phosphoramidite is a phosphoramidite that is used in the synthesis of DNA. It is also known as cholesterol-1,2,3,4,5-pentaethyleneglutamate phosphoramidite. Cholesteryl-TEG Phosphoramidite has been shown to have antiviral and anticancer activity. The novel properties of this compound make it an interesting candidate for further study. This chemical is synthesized by reacting cholesteryl chloride with triethylene glycol monophosphate. It is also a modified nucleoside that contains a deoxyribonucleoside and an activated ribonucleoside.

2-Thiopseudouridine is a heterocyclic nucleoside that is used as a building block for the synthesis of natural products. 2-Thiopseudouridine is prepared by a two-step process involving the desymmetrization of pseudoisocytidine and the formation of an aminopyrimidinone. The desymmetrization reaction proceeds with high stereoselectivity to yield the desired product in high yields. Other carbocyclic nucleosides can be synthesized from 2-thiopseudouridine, such as 2-thienopyrrole and 2-pyrroline.

N4,N4,2’-O-Trimethylcytidine is a novel nucleoside that has been shown to be an anticancer drug. It inhibits the growth of cells by selectively inhibiting their DNA synthesis. N4,N4,2’-O-Trimethylcytidine is also active against viruses and is able to inhibit viral replication by blocking the synthesis of deoxyribonucleosides and phosphoramidites. This compound has been synthesized in high purity and quality with CAS No. 34218-81-0.

N6-2-(4-Aminophenyl)ethyladenosine is a carbamazepine prodrug that is converted to the active form, carbamazepine, by esterases. It has been shown to inhibit the binding of adenosine to adenosine receptor subtypes and to have an antagonistic effect on the activity of endogenous adenosine at these receptors. N6-2-(4-Aminophenyl)ethyladenosine has also been shown to act as an antagonist at the A3 adenosine receptor. This drug has been shown to reduce bronchoconstrictor responses in animal models and may be used for treating asthma. N6-2-(4-Aminophenyl)ethyladenosine has also been shown in vitro studies using human papillary muscle cells to enhance polymerase chain reactions (PCR).

8-Methyladenosine is an acid conjugate that can be found in the urine of healthy people. It is a protonated molecule that binds to a p2 subtype of the G protein-coupled receptor, which is activated by adenosine and 8-methyladenosine. This drug has been used in clinical trials for the treatment of herpes simplex virus and cervical cancer. The intramolecular hydrogen bond between the methyl group and the adenosine ring is responsible for its high binding affinity for this receptor. The glycosidic bond is formed when an 8-methyladenosine molecule attaches to a receptor on a cell surface, forming an intramolecular hydrogen bond with the receptor's amino acid side chain. This bond is broken when a protonated molecule of 8-methyladenosine enters the cell and interacts with the receptor, resulting in activation of this receptor.

4-Amino-7H-pyrrolo[2,3-d]pyrimidine hydrogen sulfate is a rearrangement product of furoxan and a potential intermediate in the biosynthesis of carboxyl compounds. It is also an hypotensive agent that was found to be effective in lowering blood pressure and lowering lipid levels. 4-Amino-7H-pyrrolo[2,3-d]pyrimidine hydrogen sulfate has been shown to have chlorine and peracetic acid reactivity. The compound can be used as a reagent for the synthesis of carboxylic acid derivatives by reacting with arylhydrazones, such as 1,1'-carbonyldiimidazole or 3,4-dimethoxybenzoylhydrazone. 4-Amino-7H-pyrrolo[2,3-d]pyrimidine hydrogen sulfate can also

2'-Deoxy-2'-fluoroguanosine-5'-triphosphate tetralithium salt is a chemically modified nucleotide used in molecular biology and pharmaceutical research. It is a guanosine analog featuring both a 2'-fluoro substitution on the sugar and a 5'-triphosphate group, with tetralithium as the counterion to improve solubility and stability.

2'-O-Methylcytidine-5'-triphosphate sodium salt is a synthetic, modified nucleoside analog. It can be used as an antiviral agent and anticancer drug to inhibit viral replication and tumor growth. 2'-O-Methylcytidine-5'-triphosphate sodium salt has the ability to activate cellular DNA synthesis. This compound also inhibits RNA polymerase activity in cancer cells, which inhibits the production of proteins vital for cell division. 2'-O-Methylcytidine-5'-triphosphate sodium salt can be used as a phosphoramidite building block for the synthesis of oligonucleotides with novel structures.

L-Adenosine 5'-triphosphate sodium salt is a monophosphate, diphosphate, and triphosphate analog of adenosine that is used as an antiviral agent. L-Adenosine 5'-triphosphate sodium salt is a synthetic nucleoside that is modified at the ribose sugar to form a phosphoramidite. This modification increases the stability of the molecule and prevents hydrolysis by ribonucleases. L-Adenosine 5'-triphosphate sodium salt is also known as Ado-5'-P or ATPγS.

5'-O-DMT-2'-O-methyl-5-methyluridine is a modified nucleoside that is used in the synthesis of DNA. It is an anticancer drug and antiviral agent. 5'-O-DMT-2'-O-methyl-5-methyluridine has been shown to inhibit the growth of leukemia cells, even when they are resistant to other drugs. It also inhibits certain viruses, such as herpes simplex virus type 1 (HSV1), by preventing viral replication and inhibiting protein synthesis. This nucleoside is synthesized from 5'-O-DMT and 2'-O-methylcytosine.

5'-O-Tosyl-2',3'-O-isopropylideneadenosine is a novel modified nucleoside with antiviral and anticancer activities. It is an activator of the enzyme ribonucleotide reductase, which converts ribonucleotides to deoxyribonucleotides. This drug has been shown to have anticancer activity in a variety of tumor cell lines, including leukemias, lymphomas, and sarcomas. In addition, it has been shown to be active against HIV and herpes simplex virus type 1 (HSV-1). 5'-O-Tosyl-2',3'-O-isopropylideneadenosine is also known by CAS No. 5605-63-0.

2',3'-Dideoxy-3'-fluoro-5-methylcytidine (ddFMdC) is a nucleoside analogue that inhibits the synthesis of DNA by terminating DNA chain elongation. It is a purine analog and has been shown to be active against HIV in vivo. ddFMdC also terminates the DNA strand, which prevents polymerase from extending the strand. ddFMdC has been shown to be chemically stable, with no changes in stereochemistry during the course of vivisection trials. The antiviral agent ddFMdC has been used in the treatment of hepatoblastoma, a form of liver cancer, and retroviruses.

N4-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-MMT-cytidine 3'-CE phosphoramidite is a novel nucleoside analog that has been synthesized by the incorporation of a methyl group at the 5′ position. This modification results in an increased cytotoxicity and cellular uptake in cancer cells. N4-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-MMT-cytidine 3'-CE phosphoramidite also inhibits the replication of HIV and herpes simplex virus type 1 (HSV1) and type 2 (HSV2), which are responsible for AIDS and genital herpes, respectively. N4 - Benzoyl - 2 ' - O - tert - butyldimethylsilyl - 5 ' - O - MMT - cytidine 3' CE phosphoram

2'-C-Methyladenosine 5'-triphosphate triethyl ammonium salt is a synthetic nucleotide analog of adenosine triphosphate (ATP), modified at the 2'-carbon of the ribose ring. This molecule has potential applications in biochemical, enzymatic, and antiviral research, particularly in studies involving RNA synthesis and viral RNA polymerases.

2'-Deoxy-N2-DMF-5'-O-DMT-guanosine is a monophosphate nucleoside that has antiviral, anticancer, and high purity properties. It is synthesized by the phosphoramidite method from 2'-deoxy-N2-DMF and 5'-O-DMT guanosine. This compound has been shown to inhibit the growth of human cancer cells in vitro and in vivo. It also inhibits HIV replication in vitro and is not toxic to normal cells.

3'-Amino-2',3'-dideoxyguanosine's lack of a 3'-hydroxyl group makes it a chain terminator for DNA polymerase, a key application in Sanger sequencing. Additionally, the 3'-amino group serves as a functional handle for modifying the 3' end of oligonucleotides with various labels or conjugates, expanding their utility in research and diagnostics. The lithium salt ensures better handling and solubility.

Ribonucleosides are a class of compounds that contain the nucleoside ribose and the phosphate group. Ribonuclesides are modified ribonucleosides that have been synthesized and modified to be more stable than standard ribonucleotide analogs. The compound 5-Trimethylstannyl-1-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)uracil is a novel nucleoside that has been shown to have anticancer, antiviral, and antiinflammatory activities in vitro. It is also an activator for phosphoramidites, which are used to modify DNA or RNA molecules. This chemical is available at high purity and quality with CAS No. 213136-14-2.

Biotin-11-cytidine-5'-triphosphate lithium salt - 1mM aqueous solution is a novel nucleotide analogue that is synthesized by the coupling of a deoxyribonucleoside with a diphosphate. It has antiviral and anticancer activity, and may also be used to treat various types of infections. Biotin-11-cytidine-5'-triphosphate lithium salt - 1mM aqueous solution is an excellent activator of DNA polymerase in vitro, which can be used in the synthesis of DNA or RNA. This product has high purity, as well as monophosphate, diphosphate, and triphosphate forms.

5’-Deoxy-5’-iodo-2’-O-(2-methoxyethyl)uridine is a synthetic nucleoside that has antiviral and anticancer properties. This compound is an activator of DNA, which promotes the synthesis of RNA and protein. 5’-Deoxy-5’-iodo-2’-O-(2-methoxyethyl)uridine (IDOX) is an analog of deoxyribonucleosides, ribonucleosides, and monophosphates. IDOX is able to inhibit the replication of certain viruses by acting as a competitive inhibitor. This compound also has the ability to inhibit tumor cells that contain pyrimidine analogs. IDOX is also effective against cancer cells that have developed resistance to chemotherapy drugs such as 5FU or methotrexate.

6-Amino-1-(2'-deoxy-a-D-ribofuranosyl)-4-methoxy-1H- pyrazolo[3,4-d]pyrimidine is a modified nucleoside that is an antiviral agent and anticancer drug. It inhibits viral replication by inhibiting the activity of DNA polymerase. 6-[Amino(2'-deoxyribofuranosyl)]-1-(2'-deoxyribofuranosyl)-4-methoxypyrazolo[3,4-d]pyrimidine has been shown to inhibit the growth of cancer cells without affecting healthy cells.

2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine is an activator, anticancer, monophosphate nucleoside that is synthesized from 2'-deoxycytidine and 5'-fluorouracil. It is a novel deoxynucleoside that has been modified to be resistant to nucleases. This product can be used in the synthesis of oligonucleotides for use as antiviral or antineoplastic agents. 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine is also known by its CAS number 1341231-51-3.

Acadesine is a purine nucleoside analogue that inhibits the synthesis of ATP in cells. Acadesine blocks phosphorylation of adenosine monophosphate (AMP) to adenosine triphosphate (ATP) by inhibiting the activity of kinase-3, an enzyme involved in the production of ATP. Acadesine also inhibits the release of ATP from muscle cells into the blood stream and preferentially targets kidney cells, thereby reducing renal injury. Acadesine has been shown to be effective at reducing proteinuria and improving renal function in rats with acute kidney injury. Acadesine also has anti-inflammatory properties due to its ability to inhibit proteins that are involved in inflammation.

Please enquire for more information about 2'-Deoxycytidine-5'-carboxylic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page

Inosine 5'-monophosphate is a monophosphate that is produced from the purine nucleotide inosine. Inosine 5'-monophosphate has been shown to inhibit the inflammatory response in human cells and mice, which may be due to its ability to inhibit the toll-like receptor TLR2 and TLR4. It also has an antiviral effect against opportunistic fungal pathogens such as Candida albicans. Inosine 5'-monophosphate also inhibits the production of reactive oxygen species by neutrophils, which may be due to its ability to inhibit polymerase chain reaction. The therapeutic potential of this drug is currently being researched for bowel diseases such as Crohn's disease and ulcerative colitis.

3’-O-tert-Butyldimethylsilyl-2’-deoxyadenosine is a nucleoside that is used as an antiviral and anticancer drug. It inhibits viral RNA synthesis by acting as a competitive inhibitor of the enzyme ribonucleotide reductase, which converts ribonucleotides to deoxyribonucleotides. 3′-O-tert-Butyldimethylsilyl-2’-deoxyadenosine has been shown to inhibit cancer cells in vitro and in vivo. This compound also has antiangiogenic effects and may inhibit tumor cell proliferation by targeting the Ras/Raf/MEK/ERK pathway.

6-Chloro-9-(2',3'-O-isopropylidene-b-D-ribofuranosyl)purine is a nucleoside that is modified by adding an isopropylidene group (i.e., a C=C bond). It is used in the synthesis of oligonucleotides and phosphoramidites. 6-Chloro-9-(2',3'-O-isopropylidene-b-D-ribofuranosyl)purine has been shown to be an activator of the DNA polymerase, which increases its rate of incorporation of deoxyribonucleotide triphosphates into DNA chains. This nucleoside also has antiviral properties and can be used as an anticancer drug, specifically for hematological malignancies such as leukemia. 6-Chloro-9-(2',3'-O-isopropylidene

3'-Deoxyadenosine CPG is a nucleoside that is synthetically manufactured. It is a monophosphate, which can be activated to a diphosphate by the enzyme phosphoramidase. 3'-Deoxyadenosine CPG has antiviral activity and is used in the treatment of Hepatitis B and C. It also has been shown to inhibit replication of DNA and RNA viruses such as HIV-1. 3'-Deoxyadenosine CPG binds to viral DNA or RNA by base pairing with the phosphate group on its 5' carbon atom, which prevents viral replication by preventing the polymerization of nucleic acids during transcription. This product is purified with an average purity of 99% and CAS number 120775-80-0.br>br> 3'-Deoxyadenosine CPG (3'-DAD) is a modified nucleoside that was synthesized for use in antiviral therapy against hepatitis B virus

N4-Benzoyl-5'-O-DMT-2'-O-(2-methoxyethyl)-5-methylcytidine is a new nucleoside analogue that is a phosphoramidite. It has been synthesized as an anticancer agent and antiviral drug. N4-Benzoyl-5'-O-DMT-2'-O-(2-methoxyethyl)-5-methylcytidine has been shown to inhibit the growth of human tumor cells in vitro, suggesting that it may have anticancer activity. This compound also inhibits viral replication by inhibiting DNA synthesis and RNA transcription in infected cells.

2'-Deoxyuridine-5'-triphosphate trisodium salt is a fluorophore that is excited by the absorption of light at wavelengths of 365 nm. The emission spectrum ranges from 380 to 500 nm and has a maximum at 480 nm. 2'-Deoxyuridine-5'-triphosphate trisodium salt can be used as a labeling agent for metal ion, molecule, or macrocyclic ligand. It can also be used as an acceptor in fluorescence energy transfer experiments.

3'-Deoxyguanosine is a nucleic acid that is involved in the synthesis of polysaccharides and proteins. It has been shown to have an inhibitory effect on the synthesis of collagen, which may be due to its ability to increase hydrogen bonding between the nitrogen atoms and oxygen atoms. 3'-Deoxyguanosine has also been shown to have a protective effect on wheat germ extract, which may be due to its ability to inhibit oxidation reactions. The chemical structure of 3'-deoxyguanosine can be synthesized by reacting deoxyribose with sodium nitrate in the presence of sulfuric acid. This reaction can be monitored using electrochemical impedance spectroscopy (EIS).

2'-Deoxy-5'-O-DMT-N2-(4-isopropylphenoxyacetyl)guanosine 3'-Me phosphoramidite is a modified nucleoside monophosphate with antiviral and anticancer activity. It is synthesized by the reaction of 2'-deoxyguanosine 5'-O-DMT (dG) with 4-isopropylphenoxyacetic acid in the presence of triethylamine and tetrazole. The product is purified by crystallization. This compound has been shown to inhibit replication of human immunodeficiency virus type 1 (HIV-1) in human lymphocytes, which may be due to its ability to inhibit the synthesis of DNA, RNA, or both.

9-(b-D-arabinofuranosyl)-N6-benzoyladenine is a novel nucleoside analogue that has been shown to be an effective anticancer agent. It is structurally related to the natural nucleosides adenosine and guanosine, but with the addition of a benzoyl group on the 9 position. This compound is also active against HIV, influenza A virus and herpes simplex virus type 1 (HSV1). It can be used as an antiviral agent in cancer therapy due to its ability to inhibit viral replication. 9-(b-D-arabinofuranosyl)-N6-benzoyladenine inhibits the growth of tumor cells by inhibiting DNA synthesis and RNA transcription. It also binds to DNA, thereby preventing DNA synthesis and RNA transcription.

N2-Benzoyl-2'-deoxy-5'-O-DMT-guanosine is a novel and potent anticancer nucleoside with antiviral activity. It is an analog of 2'-deoxy-5'-O-DMT guanosine, which was reported to be the first phosphoramidite nucleoside. N2-Benzoyl-2'-deoxy-5'-O-DMT-guanosine is an excellent candidate for DNA synthesis and has been shown to inhibit viral replication. This product is also of high purity and high quality, and can be used in research applications.

Adenine is a purine nucleoside that has guanine as its base. It has the chemical formula C5H5N5O and can be found in RNA, DNA, and ATP. Adenine is an important component of the human body because it is a key component of nucleic acids. It also plays a role in the regulation of metabolism and the production of energy. Adenine is one of the most abundant molecules in cells, making up 75% of DNA and 50% of RNA. Adenine is biosynthesized from aspartic acid by removing an amino group on aspartate to form oxaloacetate, which reacts with glyoxylate to form citric acid. This reaction requires vitamin B6 to function properly. The optimum concentration for adenine is between 10-100 mM, but it can be toxic at high concentrations (greater than 1 M). Adenine binds to sulfa drugs through hydrogen bonding interactions and also inhibits the enzyme x